-
Persistence of Oropouche virus in body fluids among imported cases in France, 2024 Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-19 Cyrille Gourjault, Laura Pezzi, Barbara Doudier, Philippe Minodier, Raphaëlle Klitting, Philippe Cano, Nazli Ayhan, Franck Touret, Gilda Grard, Guillaume A Durand, Jean-Sélim Driouich, Léa Luciani, Antoine Nougairède, Jean-Christophe Lagier, Xavier de Lamballerie, Nadim Cassir
No Abstract
-
Correction to Lancet Infect Dis 2024; 24: 1045–58 Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-19
Bézay N, Wagner L, Kadlecek V, et al. Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies. Lancet Infect Dis 2024; 24: 1045–58—The appendix of this Article has been updated as of Dec 19, 2024.
-
Pneumococcal Septic Arthritis among Adults, France, 2010–2018 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-19 Farida Hamdad, Nadim El Bayeh, Gabriel Auger, Olivia Peuchant, Frédéric Wallet, Raymond Ruimy, Florence Reibel, Christian Martin, Marie-Cécile Ploy, Frédéric Robin, Chrislène Laurens, Philippe Lanotte, Marie Kempf, Jennifer Tetu, Hélène Revillet, Isabelle Patry, Philippe Cailloux, Mélissa Azouaou, Emmanuelle Varon, Pierre Duhaut, Alain Lozniewski, Vincent Cattoir
Streptococcus pneumoniae infection is considered an uncommon cause of arthritis in adults. To determine the clinical and microbiological characteristics of pneumococcal septic arthritis, we retrospectively studied a large series of cases among adult patients during the 2010–2018 conjugate vaccine era in France. We identified 110 patients (56 women, 54 men; mean age 65 years), and cases included 82
-
Congenital toxoplasmosis: Fewer clinical signs at 3 years of age over the last 15 years but stable risk of materno-fetal transmission Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-20 Martine Wallon, Elea Ksiazek, Antoine Journé, Damien Dupont, Jean Menotti, François Peyron, Christine Binquet
Risk and severity of congenital toxoplasmosis were estimated using data from 2,455 consecutive mother/child pairs. Clinical signs at 3 years were halved in the 177 children born since 2009 compared to 1996-2008 (OR=0.49; 95% Confidence interval 0.28-0.85). Maternofetal transmission rates remained stable from 1992 to 2021.
-
A perspective on the 2021 GBD study of diarrhoeal diseases Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-18 Khitam Muhsen, Dani Cohen
No Abstract
-
Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021 Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-18
BackgroundDiarrhoeal diseases claim more than 1 million lives annually and are a leading cause of death in children younger than 5 years. Comprehensive global estimates of the diarrhoeal disease burden for specific age groups of children younger than 5 years are scarce, and the burden in children older than 5 years and in adults is also understudied. We used results from the Global Burden of Diseases
-
Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection study Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-18 Benoit Bestgen, Sam Jones, Vandana Thathy, Andrea Kuemmerle, Catalina Barcelo, Amina Haouala, Denis Gossen, Michael W Marx, Ilaria Di Resta, Maja Szramowska, Rebecca A Webster, Stacey Llewellyn, Dominic A Ritacco, Tomas Yeo, Didier Leroy, Bridget E Barber, David A Fidock, Paul Griffin, Jason Lickliter, Stephan Chalon
BackgroundNovel antimalarials are needed to address emerging resistance to artemisinin and partner drugs. We did two trials to evaluate safety, tolerability, pharmacokinetics, and activity against blood stage Plasmodium falciparum for the drug candidate MMV533. MethodsA phase 1a first-in-human (FIH) trial was conducted at Nucleus Network (Melbourne, VIC, Australia). Part 1 was a double-blind, randomised
-
MMV533, a promising new antimalarial on the horizon Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-18 Arjen M Dondorp
No Abstract
-
Endogenous Endophthalmitis Caused by Prototheca Microalga in Birman Cat, Spain Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Laura Jimenez-Ramos, Ana Ripolles-Garcia, Gianvito Lanave, Francesco Pellegrini, Miriam Caro-Suarez, Almudena Latre-Moreno, Marta Ferruz-Fernandez, Maria Luisa Palmero-Colado, Vanessa Carballes-Perez, Antonio Melendez-Lazo, Carolina Naranjo, Fernando Laguna, Vito Martella, Manuel Villagrasa
We identified Prototheca spp. microalga in ocular samples of a cat in Spain with nontreatable endogenous endophthalmitis. Within 2 years, the eye lesions progressively worsened and neurologic signs appeared, suggesting systemic spread of the infection. On multitarget sequence analysis, the feline pathogen could not be assigned to any known Prototheca species.
-
Clonal Complex 398 Methicillin-Resistant Staphylococcus aureus Producing Panton-Valentine Leukocidin, Czech Republic, 2023 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Kristýna Brodíková, Thibault Destanque, Marisa Haenni, Renáta Karpíšková
To trace evolution of Panton-Valentine leucocidin–positive clonal complex 398 methicillin-resistant Staphylococcus aureus (MRSA) in the Czech Republic, we tested 103 MRSA isolates from humans. Five (4.9%) were Panton-Valentine leucocidin–positive clonal complex 398, sequence types 1232 and 9181. Spread to the Czech Republic may result from travel to or from other countries.
-
Surveillance Strategy in Duck Flocks Vaccinated against Highly Pathogenic Avian Influenza Virus Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Sophie Planchand, Timothée Vergne, Jean-Luc Guérin, Séverine Rautureau, Guillaume Gerbier, Sébastien Lambert
Since 2016, epizootics of highly pathogenic avian influenza (HPAI) virus have threatened the poultry sector in Europe. Because conventional prevention and control measures alone were insufficient in some contexts, the European Commission authorized poultry vaccination in 2023. Subsequently, France launched a nationwide duck vaccination campaign combined with a comprehensive surveillance plan. We used
-
Cefiderocol Resistance Conferred by Plasmid-Located Ferric Citrate Transport System in Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Riccardo Polani, Alice De Francesco, Dario Tomolillo, Irene Artuso, Michele Equestre, Rita Trirocco, Gabriele Arcari, Guido Antonelli, Laura Villa, Gianni Prosseda, Paolo Visca, Alessandra Carattoli
Cefiderocol (FDC), a siderophore-cephalosporin conjugate, is the newest option for treating infection with carbapenem-resistant gram-negative bacteria. We identified a novel mechanism contributing to decreased FDC susceptibility in Klebsiella pneumoniae clinical isolates. The mechanism involves 2 coresident plasmids: pKpQIL, carrying variants of blaKPC carbapenemase gene, and pKPN, carrying the ferric
-
Global Health’s Evolution and Search for Identity Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Kevin M. De Cock
Despite earlier attempts to define global health, the discipline’s boundaries are unclear, its priorities defined more by funding high-income countries from the Global North than by global health trends. Governance and resource allocation are challenged by movements such as decolonizing global health. Inherent contradictions within global health derive from its historical evolution from tropical medicine
-
Impact of late rainy season indoor residual spraying on holoendemic malaria transmission: a cohort study in northern Zambia. J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-19 Anne C Martin,Mike Chaponda,Mbanga Muleba,James Lupiya,Mary E Gebhardt,Sophie Berube,Timothy Shields,Amy Wesolowski,Tamaki Kobayashi,Douglas E Norris,Daniel E Impoinvil,Brian Chirwa,Reuben Zulu,Paul Psychas,Matthew Ippolito,William J Moss,
BACKGROUND Indoor residual spraying (IRS) is a malaria control strategy implemented before the rainy season. Nchelenge District, Zambia is a holoendemic setting where IRS has been conducted since 2008 with little impact on malaria incidence or parasite prevalence. Pre-rainy season IRS may not reduce the post-rainy season peak abundance of the major vector, Anopheles funestus. METHODS A controlled,
-
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-17 Julia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, Maria Garcia Quesada, Scott L Zeger, Marissa K Hetrich, Yangyupei Yang, Carly Herbert, Anju Ogyu, Adam L Cohen, Inci Yildirim, Brita A Winje, Anne von Gottberg, Delphine Viriot, Mark van der Linden, Palle Valentiner-Branth, Shigeru Suga, Anneke Steens, Anna Skoczynska, Nadja Sinkovec Zorko, Tomoka Nakamura
BackgroundPneumococcal conjugate vaccines (PCVs) that are ten-valent (PCV10) and 13-valent (PCV13) became available in 2010. We evaluated their global impact on invasive pneumococcal disease (IPD) incidence in all ages. MethodsSerotype-specific IPD cases and population denominators were obtained directly from surveillance sites using PCV10 or PCV13 in their national immunisation programmes and with
-
Sustainable antimicrobial resistance surveillance: time for a global funding mechanism Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-17 Chris Painter, Direk Limmathurotsakul, Tamalee Roberts, H Rogier van Doorn, Mayfong Mayxay, Yoel Lubell, Nicholas P J Day, Paul Turner, Elizabeth A Ashley
Antimicrobial resistance (AMR) is predicted to outstrip malaria, HIV, and tuberculosis combined as the leading infectious cause of death by 2050. Strengthening the knowledge and evidence base for AMR with surveillance and research is one of the five main objectives of the WHO Global Action Plan on AMR. While recent efforts to strengthen diagnosis and surveillance have been encouraging, these are unlikely
-
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-17 Maria Garcia Quesada, Meagan E Peterson, Julia C Bennett, Kyla Hayford, Scott L Zeger, Yangyupei Yang, Marissa K Hetrich, Daniel R Feikin, Adam L Cohen, Anne von Gottberg, Mark van der Linden, Nina M van Sorge, Lucia H de Oliveira, Sara de Miguel, Inci Yildirim, Didrik F Vestrheim, Jennifer R Verani, Emmanuelle Varon, Palle Valentiner-Branth, Georgina Tzanakaki, Tomoka Nakamura
BackgroundWidespread use of pneumococcal conjugate vaccines (PCVs) has reduced vaccine-type invasive pneumococcal disease (IPD). We describe the serotype distribution of IPD after extensive use of ten-valent PCV (PCV10; Synflorix, GSK) and 13-valent PCV (PCV13; Prevenar 13, Pfizer) globally. MethodsIPD data were obtained from surveillance sites participating in the WHO-commissioned Pneumococcal Serotype
-
How have pneumococcal conjugate vaccines changed the pneumococcal disease landscape? Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-17 Claire von Mollendorf, Anna Lisa T Ong-Lim
No Abstract
-
Treatment of severe carbapenem-resistant Pseudomonas aeruginosa infections: still many uncertainties Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-16 Jean-François Timsit
No Abstract
-
Development and Implementation of a Public Health Event Management System, Nigeria, 2018–2024 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-17 James Elston, Womi-Eteng Oboma Eteng, Chikwe Ihekweazu, Isabel Oliver, Everistus Aniaku, Anwar Abubakar, Christopher T. Lee, Emmanuel Benyeogor, Iain Roddick, Sophie Logan, Ebere Okereke, Leena Inamdar, Olusola Aruna, Rejoice Luka-Lawal, Christine Manthey, Lawrence Hinkle, Gloria Nunez, Emmanuel Agogo, Rabi Usman, Emmanuel Lucky Sunday, Muntari Hassan, John Oladejo, Ifedayo Adetifa
Event management systems (EMS) are key tools for epidemic intelligence, integrating surveillance signals and incident response, although international standards to inform development are lacking. We describe the Nigeria Centre for Disease Control and Prevention (NCDC) SITAware, a software capable of operating with low internet bandwidth to generate notifications, reports, and spatiotemporal dashboards
-
Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-17 Jiyan Ma, Yang Yang, Yangmu Huang
Since the severe acute respiratory syndrome outbreak in 2003, China has invested substantial efforts in promoting scientific and technological advances for medical countermeasures against high-threat pathogens. The examination of China’s landscape identifies progress and gaps in research and development (R&D) and also highlights management and regulatory issues that should be of concern to other countries
-
Spread of Antifungal-Resistant Trichophyton indotineae, United Kingdom, 2017–2024 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-17 Alireza Abdolrasouli, Richard C. Barton, Andrew M. Borman
We describe 157 cases of Trichophyton indotineae infection in the United Kingdom, mostly in patients linked to southern Asia. T. indotineae is spreading in the United Kingdom and accounts for 38% of dermatophyte isolates referred to the UK National Mycology Reference Laboratory. Clinicians should suspect T. indotineae in tinea corporis cases.
-
Detection of Prions in Wild Pigs (Sus scrofa) from Areas with Reported Chronic Wasting Disease Cases, United States Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-17 Paulina Soto, Francisca Bravo-Risi, Rebeca Benavente, Tucker H. Stimming, Michael J. Bodenchuk, Patrick Whitley, Clint Turnage, Terry R. Spraker, Justin Greenlee, Glenn Telling, Jennifer Malmberg, Thomas Gidlewski, Tracy Nichols, Vienna R. Brown, Rodrigo Morales
Using a prion amplification assay, we identified prions in tissues from wild pigs (Sus scrofa) living in areas of the United States with variable chronic wasting disease (CWD) epidemiology. Our findings indicate that scavenging swine could play a role in disseminating CWD and could therefore influence its epidemiology, geographic distribution, and interspecies spread.
-
Social Contact Patterns in Rural and Urban Settings, Mozambique, 2021–2022 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-17 Moses C. Kiti, Charfudin Sacoor, Obianuju G. Aguolu, Alana Zelaya, Holin Chen, Sara S. Kim, Nilzio Cavele, Edgar Jamisse, Corssino Tchavana, Americo Jose, Ivalda Macicame, Orvalho Joaquim, Noureen Ahmed, Carol Y. Liu, Inci Yildirim, Kristin Nelson, Samuel M. Jenness, Herberth Maldonado, Momin Kazi, Rajan Srinivasan, Venkata R. Mohan, Alessia Melegaro, Fauzia Malik, Azucena Bardaji, Saad B. Omer, Ben
Few sources have reported empirical social contact data from resource-poor settings. To address this shortfall, we recruited 1,363 participants from rural and urban areas of Mozambique during the COVID-19 pandemic, determining age, sex, and relation to the contact for each person. Participants reported a mean of 8.3 (95% CI 8.0–8.6) contacts per person. The mean contact rates were higher in the rural
-
Salmonella enterica Serovar Abony Outbreak Caused by Clone of Reference Strain WDCM 00029, Chile, 2024 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Alejandro Piña-Iturbe, Diego Fredes-García, Patricia García, Lorena Porte, Timothy J. Johnson, Randall S. Singer, Magaly Toro, José M. Munita, Andrea I. Moreno-Switt
A Salmonella enterica serovar Abony outbreak occurred during January–April 2024 in Chile. Genomic evidence indicated that the outbreak strain was a clone of reference strain WDCM 00029, which is routinely used in microbiological quality control tests. When rare or unreported serovars cause human infections, clinicians and health authorities should request strain characterization.
-
Identification and Characterization of Vancomycin-Resistant Staphylococcus aureus CC45/USA600, North Carolina, USA, 2021 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Jennifer K. MacFarquhar, Anumita Bajpai, Teresa Fisher, Chad Barr, Alyssa G. Kent, Susannah L. McKay, Davina Campbell, Amy S. Gargis, Rocio Balbuena, David Lonsway, Maria Karlsson, Maroya Spalding Walters, D. Cal Ham, William A. Glover
Vancomycin-resistant Staphylococcus aureus (VRSA) is a rare but serious public health concern. We describe a VRSA case in North Carolina, USA. The isolate from the case belonged to the USA600 lineage and clonal complex 45. No transmission was identified. Confirmed VRSA cases should include a thorough investigation and public health response.
-
Neisseria meningitidis Serogroup Y Sequence Type 1466 and Urogenital Infections Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Sebastiaan J. van Hal, Thomas Le, Frances Jenkins, Ratan L. Kundu, E. Athena Limnios, Lucy McNamara, Shalabh Sharma, Ellen N. Kersh, Monica M. Lahra
Neisseria meningitidis is a common commensal bacterium of the nasopharynx that can cause invasive meningococcal disease (IMD). In comparison, N. gonorrhoeae is always a pathogen usually limited to mucosal sites. However, increased evidence for overlapping clinical syndromes is emerging. We compared N. meningitidis samples from a urogenital outbreak in Australia with sequences from the United States
-
Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Species Trichuris incognita with Low Sensitivity to Albendazole/Ivermectin Combination Treatment Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Abhinaya Venkatesan, Rebecca Chen, Max Bär, Pierre H.H. Schneeberger, Brenna Reimer, Eveline Hürlimann, Jean T. Coulibaly, Said M. Ali, Somphou Sayasone, John Soghigian, Jennifer Keiser, John Stuart Gilleard
Albendazole/ivermectin combination therapy is a promising alternative to benzimidazole monotherapy alone for Trichuris trichiura control. We used fecal DNA metabarcoding to genetically characterize Trichuris spp. populations in patient samples from Côte d’Ivoire showing lower (egg reduction rate <70%) albendazole/ivermectin sensitivity than those from Laos and Tanzania (egg reduction rates >98%). Internal
-
Cluster of Legionellosis Cases Associated with Manufacturing Process, South Carolina, USA, 2022 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-18 Hani M. Mohamed, Lindsay Zielinski, Abdoulaye Diedhiou, Nakia Clemmons, Jessica C. Smith, Jessica L. Rinsky, Troy Ritter, Melisa Willby, Nancy Burton, Karl Feldmann, Kevin Dunn, Rebecca Whisenhunt, Victoria Greer, Alberto M. Acosta, Mitchell Garber, Claressa E. Lucas, Kelley C. Henderson, Chris Edens, Linda Bell
Evolving technology and the development of new devices that can aerosolize water present a risk for new sources of Legionella bacteria growth and spread within industrial settings. We investigated a cluster of legionellosis among employees of a manufacturing facility in South Carolina, USA, and found 2 unique equipment sources of Legionella bacteria. The cluster of cases took place during August–November
-
Morbidity and Mortality Risk Among People With Human Immunodeficiency Virus and Central or Visceral Adiposity: A Targeted Literature Review. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-18 Alison M Bjornson,Roger J Bedimo,Shelagh M Szabo,Hannah Rochon,Daniel Lee
BACKGROUND Given the known relationship between human immunodeficiency virus (HIV), antiretroviral therapies, and excess visceral adipose tissue (VAT), this review sought to characterize risk of negative health outcomes associated with excess VAT and increased waist circumference (WC) in people with HIV (PWH). METHODS Comprehensive targeted literature searches were conducted in Medline/Embase (27 June
-
Glucocorticoid dosing and implications for vaccination: Evolution of global definitions. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-18 Xia Wang,Cyra Patel,Michelle L Giles,Penelope Burns,Kristine Macartney,Benjamin Teh,Phoebe C Williams
Despite widespread adoption of "high-dose" glucocorticoid definitions across international immunisation guidelines (i.e., prednisone-equivalent dosing >20 mg/day, or >2 mg/kg/day in children), the rationale remains unclear. Literature searches were performed through academic databases for this narrative review to identify relevant evidence regarding glucocorticoid dosing on vaccine responses and safety
-
Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-18 Liana Macpherson,Sandra V Kik,Matteo Quartagno,Francisco Lakay,Marche Jaftha,Nombuso Yende,Shireen Galant,Saalikha Aziz,Remy Daroowala,Richard Court,Arshad Taliep,Keboile Serole,Rene T Goliath,Nashreen Omar Davies,Amanda Jackson,Emily Douglass,Bianca Sossen,Sandra Mukasa,Friedrich Thienemann,Taeksun Song,Morten Ruhwald,Robert J Wilkinson,Anna K Coussens,Hanif Esmail,
BACKGROUND World Health Organization (WHO) tuberculosis (TB) screening guidelines recommend computer-aided detection (CAD) software for chest radiograph (CXR) interpretation. However, studies evaluating their diagnostic and prognostic accuracy are limited. METHODS We conducted a prospective cohort study of household contacts of rifampicin-resistant TB in South Africa. Participants underwent baseline
-
Impact of Anti-CD4 Autoantibodies on Immune Reconstitution in People With Advanced Human Immunodeficiency Virus Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-18 Brian P Epling, Andrea Lisco, Maura Manion, Elizabeth Laidlaw, Frances Galindo, Megan Anderson, Gregg Roby, Virginia Sheikh, Stephen A Migueles, April Poole, Ainhoa Perez-Diez, Xiangdong Liu, V Koneti Rao, Peter D Burbelo, Irini Sereti
Background Despite suppressive antiretroviral therapy (ART), 15%–30% of people with human immunodeficiency virus (HIV) experience a limited recovery of CD4 T cells. Although autoantibodies against the CD4 receptor have previously been identified in people with HIV (PWH), little is known about their longitudinal impact on CD4 T-cell reconstitution. Methods Anti-CD4 autoantibodies were evaluated by the
-
Relationship Between Acute Severe Acute Respiratory Syndrome Coronavirus 2 Viral Clearance and Long Coronavirus 2019 (Long COVID) Symptoms: A Cohort Study Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-18 Carly Herbert, Annukka A R Antar, John Broach, Colton Wright, Pamela Stamegna, Katherine Luzuriaga, Nathaniel Hafer, David D McManus, Yukari C Manabe, Apurv Soni
Background The relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral dynamics during acute infection and the development of long coronavirus disease 2019 (COVID-19), or “long COVID,” is largely unknown. Methods Between October 2021 and February 2022, 7361 people not known to have COVID-19 self-collected nasal swab samples for SARS-CoV-2 reverse-transcription polymerase
-
Patterns and cofactors of polyfunctional mycobacteria-specific T cell response restoration following 6-month antiretroviral treatment in children living with HIV J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-18 Cheryl L Day, Irene N Njuguna, Lisa Marie Cranmer, Wendy E Whatney, Rachel A Pearson, Cecilia S Lindestam Arlehamn, Alessandro Sette, Sylvia M LaCourse, Jaclyn N Escudero, Loren E Sasser, Cyrus Mugo, Hellen Moraa Okinyi, Elizabeth Maleche-Obimbo, Dalton C Wamalwa, Grace C John-Stewart
Background Despite immune restoration after initiation of antiretroviral treatment (ART), the risk of tuberculosis (TB) persists in children living with HIV (CLHIV). We determined patterns of immune restoration of mycobacteria-specific T cells following ART in CLHIV. Methods CD4 and CD8 T cell activation and memory phenotype and functional profiles before and 6 months after ART were evaluated in peripheral
-
Diversity in Naturally Acquired Immunity to Group B Streptococcus: A Comparative Study of Women from Bangladesh, Malawi, and the United Kingdom J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-18 Shadia Khandaker, Shilpee Sharma, Tom Hall, Suzanna Lim, Janne Lehtonen, Stephanie Leung, Zabed Bin Ahmed, Andrew Gorringe, Samir K Saha, Arnaud Marchant, Kirsty Le Doare, Aras Kadioglu, Neil French
Background Significant disparities in Group B Streptococcus (GBS) colonisation and neonatal disease rates have been documented across different geographical regions. For example, Bangladesh reports notably lower rates compared to the United Kingdom (UK) and Malawi. This study investigates whether this epidemiological variability correlates with the immune response to GBS in these regions. Methods Qualitative
-
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study Lancet Infect Dis (IF 36.4) Pub Date : 2024-12-16 Ryan K Shields, Lilian M Abbo, Renee Ackley, Samuel L Aitken, Benjamin Albrecht, Ahmed Babiker, Rachel Burgoon, Renzo Cifuentes, Kimberly C Claeys, Brooke N Curry, Kathryn E DeSear, Jason C Gallagher, Esther Y Golnabi, Alan E Gross, Jonathan Hand, Emily L Heil, Krutika M Hornback, Keith S Kaye, Trieu-Vi Khuu, Megan E Klatt, Jason M Pogue
BackgroundCeftolozane–tazobactam and ceftazidime–avibactam are preferred treatment options for multidrug-resistant Pseudomonas aeruginosa infections; however, real-world comparative effectiveness studies are scarce. Pharmacokinetic and pharmacodynamic differences between the agents might affect clinical response rates. We aimed to compare the effectiveness of ceftolozane–tazobactam and ceftazidime–avibactam
-
A Step Forward in Hypervirulent Klebsiella pneumoniae Diagnostics Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-16 Thomas A. Russo, Francois Lebreton, Patrick T. McGann
Hypervirulent Klebsiella pneumoniae (hvKp) can cause life-threatening infections in healthy community members. HvKp Infections often involve multiple sites, some of which are unusual for classical K. pneumoniae (cKp) infections, such as the central nervous system, eyes, and fascia. The acquisition of antimicrobial resistance by hvKp has resulted in concerns of an emerging superbug. This concern is
-
Management, outcomes and predictors of mortality of Cryptococcus infection in patients without HIV: a multicentre study in 46 hospitals from Australia and New Zealand Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-17 Julien Coussement, Christopher H Heath, Matthew B Roberts, Rebekah J Lane, Tim Spelman, Olivia C Smibert, Anthony Longhitano, C Orla Morrissey, Blake Nield, Monica Tripathy, Joshua S Davis, Karina J Kennedy, Sarah A Lynar, Lucy C Crawford, Simeon J Crawford, Benjamin J Smith, Andrew P Gador-Whyte, Rose Haywood, Andrew A Mahony, Julia C Howard, Genevieve B Walls, Gabrielle M O’Kane, Matthew T Broom
Background Limited data exist regarding outcomes of cryptococcosis in patients without HIV with few studies having compared outcomes of Cryptococcus gattii, versus C. neoformans, infection. Methods We conducted a retrospective study in 46 Australian and New Zealand hospitals to determine the outcomes of cryptococcosis in patients without HIV diagnosed between 2015 and 2019, and compared outcomes of
-
A 5-Month-Old Infant With a Complicated Holiday Souvenir. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-17 Iris Voogd,Sanne A S E Kooistra,Jamie A van der Meer,Soëba Ehsary,Clementien Vermont,Els van Nood,Marjolijn S W Quaak
-
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-17 Catherine A Chappell, Jennifer J Kiser, Kristina M Brooks, Riley Randolph, Ingrid S Macio, Leslie A Meyn, Sam MaWhinney, Anne-Marie Rick, Gysella B Muniz, Kyung min Kwon, Cathleen Letterio, Sarjita Naik, Bruce Kreter, Katherine E Bunge, Elizabeth E Krans, Sharon L Hillier
Background Treatment of hepatitis C virus (HCV) during pregnancy can cure maternal HCV and prevent perinatal HCV transmission. The primary objective was to compare the pharmacokinetics (PK) of sofosbuvir/velpatasvir (SOF/VEL) in pregnant versus nonpregnant people. Methods Pregnant people with chronic HCV infection were enrolled between 23-25 weeks’ gestation and were provided SOF/VEL daily for 12 weeks
-
Independent FDA Analyses of Nirmatrelvir/Ritonavir Resistance in the Phase 2/3 Trials EPIC-HR and EPIC-SR Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-17 Jonathan M O Rawson, Eric F Donaldson, Julian J O’Rear, Patrick R Harrington
Background PAXLOVID consists of nirmatrelvir, an inhibitor of SARS-CoV-2 main protease (Mpro), copackaged with ritonavir, a pharmacokinetic enhancer. Nirmatrelvir/ritonavir received emergency use authorization in the United States in 2021 and was approved in 2023. However, there is limited published information on SARS-CoV-2 clinical resistance to nirmatrelvir/ritonavir. Methods To investigate SARS-CoV-2
-
Community-based TB isolation decisions require individualization based on effectiveness and duration of treatment, community risks and patient harms. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-17 Maunank Shah,Ruvandhi Nathavitharana,Joseph Burzynski
-
Is low yield follow-up fungal PCR of a prior negative result reliable? Some consideration on negative predictive value, the target population and anti-fungal prophylaxis. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-17 Shuangshuang Yang,Linbo Zhang,Junnan Li,Ju Cao
-
State-of-the-Art Review: Diagnosis and Management of Spinal Implant Infections Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-17 Don Bambino Geno Tai, Robin Patel, Francis Lovecchio, Thomas Kwee, Marjan Wouthuyzen-Bakker
Spinal implant infections are a serious complications of instrumented spinal fusion surgeries, carrying high morbidity and complex management challenges. Early postoperative infections may manifest with wound-healing issues, back pain, and fevers. Magnetic resonance imaging (MRI) is the preferred imaging modality, but can be limited by metal artifacts. For cases with stable implants, surgical debridement
-
Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-17 James W Antoon, Justin Z Amarin, Olla Hamdan, Tess Stopczynski, Laura S Stewart, Marian G Michaels, John V Williams, Eileen J Klein, Janet A Englund, Geoffrey A Weinberg, Peter G Szilagyi, Jennifer E Schuster, Rangaraj Selvarangan, Christopher J Harrison, Julie A Boom, Leila C Sahni, Flor M Muñoz, Mary Allen Staat, Elizabeth P Schlaudecker, James D Chappell, Benjamin R Clopper, Heidi L Moline, Angela
Background Guidelines state that all hospitalized children with suspected or confirmed influenza receive prompt treatment with influenza-specific antivirals. We sought to determine the frequency of, and factors associated with, antiviral receipt among hospitalized children. Methods We conducted active surveillance of children presenting with fever or respiratory symptoms from 1 December 2016 to 31
-
Candida albicans recovered from persistent candidemia exhibit enhanced virulence traits J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-17 Felipe de Camargo Ribeiro, Karoline Kristina Kemmerich, Juliana Caparroz Gonçale, Juliana Campos Junqueira, Mohammad Mannan, Sunna Nabeela, Arnaldo Lopes Colombo, Priya Uppuluri
Candida albicans catheter-related candidemia is largely driven by microbial adhesion and biofilm formation on central venous catheters. Cells that disperse from these biofilms can enter the bloodstream, spread to distant organs, and sustain the cycle of infection. In this study, we investigated the virulence potential of C. albicans isolates obtained from the blood of catheterized patients experiencing
-
Incorporating incubation period distributions to precisely estimate the association between rainfall and Legionella infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-17 Kelsie Cassell, Joshua L Warren, Christopher Heneghen, Daniel M Weinberger
Background Multiple studies have shown a positive relationship between weather events and, 1 to 2 weeks later, Legionnaires’ disease (LD) cases. Narrowing this time window of association can help determine whether the mechanism linking rainfall and relative humidity to sporadic LD is direct or indirect. Due to the large number of daily water interactions and low incidence of LD, we propose a new Bayesian
-
Imipenem pharmacokinetics/pharmacodynamics in preclinical hollow fiber model, dose-finding in virtual patients, and clinical evidence of efficacy for Mycobacterium abscessus lung disease J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-17 Sanjay Singh, Tawanda Gumbo, Jann-Yuan Wang, Gunavanthi D Boorgula, Andrew Burke, Hung-Ling Huang, Pamela J McShane, Rodolfo Amaro-Galvez, Jane E Gross, Santosh Aryal, Scott K Heysell, Shashikant Srivastava
Background Guideline-based therapy (GBT) for Mycobacterium abscessus (Mab) lung disease achieves sputum culture conversion rates (SCC) of 35%. This poor GBT efficacy is mirrored in the hollow fiber system model of Mab (HFS-Mab). While imipenem is part of GBT, biological effect with or without β-lactamase inhibitors, is unproven. Methods We performed imipenem/relebactam minimum inhibitory concentration
-
Phylodynamics for HIV Prevention: A Miami-Dade Case Study J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-17 Sanjay R Mehta, Alan B Wells, Colby Cohen, Angela Campbell, Michelle Truong, Susan J Little, Antoine Chaillon
Background To date, HIV molecular epidemiology (HIV ME) has been primarily used to identify clusters of related infections (cluster detection and response [CDR]) and then address interventions to these clusters. Community groups have raised concern regarding CDR regarding privacy and ethical concerns. Here we demonstrate how an alternative approach to HIV ME can provide public health benefit. Methods
-
Hansen’s Disease: A Complete Clinical Guide Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-12-15 Rezhan Hussein
Books and Media
-
Follow-up Fungal PCR Testing on Plasma and BAL is Low Yield. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-16 Niaz Banaei
-
Optimal timing to discontinue respiratory isolation among patients with pulmonary TB. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-16 Carlos Acuña-Villaorduña,Edward C Jones-López,Grant Theron,Keertan Dheda,Kevin P Fennelly
-
-
Long-Lived Plasma Cells can't forget the Original Antigenic Sin. J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-16 Chika Edward Uzoigwe
-
Anelloviruses and Cancer J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-16 Jason Y Tang, Trevor B Chen, Valentina L Kouznetsova, Igor F Tsigelny
Anelloviruses are among the most prevalent viruses within the human virome, detected in over 90% of healthy individuals. Despite their ubiquity, the role of anelloviruses in human health remains elusive. This review examines the potential associations of anelloviruses torque teno virus (TTV), torque teno midi virus (TTMDV), and torque teno mini virus (TTMV) with various cancers, highlighting the mixed
-
Evaluating Sex Differences in Pneumococcal Disease Burden and Vaccination Effectiveness in Adults: A Population-Based Study J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-16 María José Forcadell-Peris, Àngel Vila-Córcoles, Cinta de Diego-Cabanes, Verònica Torras Vives, Olga Ochoa-Gondar, Eva M Satué-Gracia
Background Information concerning sex differences in pneumococcal vaccine effectiveness in adults is scarce. The main aim of this study is to compare the differences in clinical effectiveness of pneumococcal vaccination between male and female adults. Methods Population-based cohort study involving 1,108,634 women and 951,011 men aged ≥50years in Catalonia, Spain. Baseline characteristics of cohort
-
Antibody Levels from High-Throughput Variant-Specific SARS-CoV-2 Anti-Spike IgG and ACE2 Neutralization Assays Correlate with COVID Infection Risk in a Large Population J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-16 Marni B Jacobs, Alex E Clark, Nicole H Goldhaber, Holly D Valentine, Andrea Rivera, Toan Ngo, Tom Barber, Jacqueline Holmes, Brittany Manfredi, Aaron F Garretson, William Bray, Rob Knight, Christopher A Longhurst, Aaron F Carlin, Peter De Hoff, Louise C Laurent
Background SARS-CoV-2 antibody levels have been proposed as a correlate of protection (CoP) from infection. Yet, large-scale prospective studies of cost-effective scalable antibody measures as predictors of infection under real-world conditions are limited. We examined whether antibody levels measured using high-throughput variant-specific SARS-CoV-2 anti-spike immunoglobulin G (IgG) and ACE2-neutralization
-
B-Cell Activation Gene Signature in Blood and Liver of Hepatitis B e Antigen-Positive Patients With Immune Active Chronic Hepatitis B. J. Infect. Dis. (IF 5.0) Pub Date : 2024-12-16 Zgjim Osmani,Boris J B Beudeker,Zwier M A Groothuismink,Robert J de Knegt,Raymond T Chung,Jeroen Aerssens,Jacques Bollekens,Harry L A Janssen,Adam J Gehring,Georg M Lauer,Alex K Shalek,Harmen J G van de Werken,Andre Boonstra
BACKGROUND Studies on chronic hepatitis B virus (HBV) infection have shown immune dysfunction involving multiple cell types, including T cells. B cells have been evaluated more recently, but in contrast to T cells, more pronounced activation of circulating B cells has been reported. To gain more insight into the activation status of B cells, we investigated gene profiles of B cells in the blood and
-
Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine is Reduced in Infants Immunized during the Respiratory Viral Season Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-12-15 Ron Dagan, Bart A van der Beek
Introduction We hypothesized that response to infant pneumococcal conjugate vaccines (PCVs), administered during peak respiratory viral seasons could be blunted, particularly to higher carrier-load PCVs. Methods We did a post-hoc analysis of a large, double-blind, randomized study comparing 13-valent vs. 7-valent PCVs (PCV13; PCV7) administered to infants (at 2, 4, 6, and 12 months). We defined respiratory